Transgene begins trials of head and neck cancer vaccineVirus-based immunotherapy biotech Transgene is to begin clinical trials of its head and neck cancer drug candidate TG4050 Share XTransgene begins trials of head and neck cancer vaccinehttps://pharmaphorum.com/news/transgene-begins-trials-of-head-and-neck-cancer-vaccine/
